Annual Accounts Payable
$866.00 K
+$369.30 K+74.35%
December 1, 2023
Summary
- As of February 18, 2025, DRMA annual accounts payable is $866.00 thousand, with the most recent change of +$369.30 thousand (+74.35%) on December 1, 2023.
- During the last 3 years, DRMA annual accounts payable has risen by +$761.70 thousand (+730.30%).
- DRMA annual accounts payable is now at all-time high.
Performance
DRMA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$863.60 K
-$463.60 K-34.93%
September 1, 2024
Summary
- As of February 18, 2025, DRMA quarterly accounts payable is $863.60 thousand, with the most recent change of -$463.60 thousand (-34.93%) on September 1, 2024.
- Over the past year, DRMA quarterly accounts payable has stayed the same.
- DRMA quarterly accounts payable is now -34.93% below its all-time high of $1.33 million, reached on June 1, 2024.
Performance
DRMA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DRMA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +74.3% | 0.0% |
| 3 y3 years | +730.3% | 0.0% |
| 5 y5 years | +156.8% | 0.0% |
DRMA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.3% | -34.9% | +97.3% |
| 5 y | 5-year | at high | +730.3% | -34.9% | +728.0% |
| alltime | all time | at high | +730.3% | -34.9% | +728.0% |
Dermata Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $863.60 K(-34.9%) |
| Jun 2024 | - | $1.33 M(+61.4%) |
| Mar 2024 | - | $822.50 K(-5.0%) |
| Dec 2023 | $866.00 K(+74.4%) | $866.00 K(+82.5%) |
| Sep 2023 | - | $474.50 K(+8.4%) |
| Jun 2023 | - | $437.80 K(-11.2%) |
| Mar 2023 | - | $492.90 K(-0.8%) |
| Dec 2022 | $496.70 K | $496.70 K(+2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $483.70 K(-20.5%) |
| Jun 2022 | - | $608.80 K(-8.1%) |
| Mar 2022 | - | $662.20 K(+28.5%) |
| Dec 2021 | $515.20 K(+394.0%) | $515.20 K(-33.1%) |
| Sep 2021 | - | $769.90 K(-12.6%) |
| Jun 2021 | - | $881.30 K(+80.6%) |
| Mar 2021 | - | $488.10 K(+368.0%) |
| Dec 2020 | $104.30 K(-69.1%) | $104.30 K |
| Dec 2019 | $337.20 K | - |
FAQ
- What is Dermata Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Dermata Therapeutics?
- What is Dermata Therapeutics annual accounts payable year-on-year change?
- What is Dermata Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Dermata Therapeutics?
- What is Dermata Therapeutics quarterly accounts payable year-on-year change?
What is Dermata Therapeutics annual accounts payable?
The current annual accounts payable of DRMA is $866.00 K
What is the all time high annual accounts payable for Dermata Therapeutics?
Dermata Therapeutics all-time high annual accounts payable is $866.00 K
What is Dermata Therapeutics annual accounts payable year-on-year change?
Over the past year, DRMA annual accounts payable has changed by +$369.30 K (+74.35%)
What is Dermata Therapeutics quarterly accounts payable?
The current quarterly accounts payable of DRMA is $863.60 K
What is the all time high quarterly accounts payable for Dermata Therapeutics?
Dermata Therapeutics all-time high quarterly accounts payable is $1.33 M
What is Dermata Therapeutics quarterly accounts payable year-on-year change?
Over the past year, DRMA quarterly accounts payable has changed by $0.00 (0.00%)